Safety and Efficacy of Bivalirudin in Acute Coronary Syndromes

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|12|1191-1196

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.12, 2008-04, pp. : 1191-1196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions

By White Harvey D   Chew Derek P  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Bivalirudin: A Pharmacoeconomic Profile of its Use in Patients with Acute Coronary Syndromes

By Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 343-359

Adis International

Access to resources Recommend Favorite

Bivalirudin: In Patients with Acute Coronary Syndromes Planned for Urgent or Early Intervention

By Deeks Emma D.   Curran Monique P.  

Drugs, Vol. 68, Iss. 16, 2008-01 ,pp. : 2345-2356

Adis International

Access to resources Recommend Favorite

Bivalirudin: A Review of its Potential Place in the Management of Acute Coronary Syndromes

By Carswell C.I.   Plosker G.L.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 841-870

Adis International

Access to resources Recommend Favorite

Fondaparinux in acute coronary syndromes

By Chaturvedi Vivek   Karthikeyan Ganesan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1615-1623

Informa Healthcare

Access to resources Recommend Favorite